--

Professor Anthony Wierzbicki trained at the University of Cambridge attended clinical school in Oxford and qualified in 1986. He was appointed consultant in chemical pathology and director of the lipid and cardiovascular prevention unit at Guy's & St Thomas' Hospitals in 1994.

Professor Wierzbicki's work in the field of atherosclerosis, which comprises more than 400 publications, has led to appointments as a Fellow of National Association of Clinical Biochemistry (USA) and the American Heart Association (arteriosclerosis and blood pressure sections). He has been a trustee of HEART-UK (the UK cholesterol charity) and is a member of many national and international societies. He has sat on many UK government panels in cardiovascular medicine including for the National Institute of Clinical Excellence.

Diseases, Medical Tests and Treatments

• Minimise description of Clinical interests
• Metabolic medicine
• Chemical pathology
• Cardiovascular medicine
• Hyperlipidaemia and obesity
• General medicine
• Minimise description of Clinical interests
• Metabolic medicine
• Chemical pathology
• Cardiovascular medicine
• Hyperlipidaemia and obesity
• General medicine